Forum Financial Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $932K | Hold |
2,094
| – | – | 0.01% | 231 |
|
2025
Q1 | $1.02M | Buy |
2,094
+246
| +13% | +$119K | 0.02% | 206 |
|
2024
Q4 | $744K | Buy |
1,848
+53
| +3% | +$21.3K | 0.01% | 263 |
|
2024
Q3 | $835K | Sell |
1,795
-4
| -0.2% | -$1.86K | 0.01% | 213 |
|
2024
Q2 | $843K | Buy |
1,799
+12
| +0.7% | +$5.63K | 0.02% | 202 |
|
2024
Q1 | $747K | Hold |
1,787
| – | – | 0.01% | 238 |
|
2023
Q4 | $727K | Sell |
1,787
-10
| -0.6% | -$4.07K | 0.01% | 207 |
|
2023
Q3 | $625K | Buy |
1,797
+10
| +0.6% | +$3.48K | 0.01% | 228 |
|
2023
Q2 | $629K | Buy |
1,787
+8
| +0.4% | +$2.82K | 0.01% | 244 |
|
2023
Q1 | $561K | Sell |
1,779
-60
| -3% | -$18.9K | 0.02% | 239 |
|
2022
Q4 | $531K | Sell |
1,839
-58
| -3% | -$16.7K | 0.02% | 240 |
|
2022
Q3 | $549K | Hold |
1,897
| – | – | 0.03% | 204 |
|
2022
Q2 | $535K | Buy |
1,897
+208
| +12% | +$58.7K | 0.03% | 221 |
|
2022
Q1 | $440K | Sell |
1,689
-75
| -4% | -$19.5K | 0.02% | 268 |
|
2021
Q4 | $387K | Buy |
+1,764
| New | +$387K | 0.02% | 319 |
|